Medical Technology - Kuwait

  • Kuwait
  • In 2024, the revenue in the Medical Technology market market in Kuwait is estimated to reach US$846.50m.
  • The largest market within this market is Medical Devices, which is projected to have a market volume of US$716.40m in the same year.
  • It is expected that the revenue will experience an annual growth rate of 6.16% from 2024 to 2028, resulting in a market volume of US$1,075.00m by 2028.
  • When compared globally, the United States is expected to generate the highest revenue in the Medical Technology market market, with an estimated amount of US$215.80bn in 2024.
  • Kuwait's medical technology market is witnessing a surge in demand for advanced diagnostic devices and telemedicine services.

Key regions: United States, Germany, China, Japan, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Medical Technology market in Kuwait has been experiencing significant growth in recent years, driven by customer preferences for advanced healthcare solutions, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Kuwait have been shifting towards more advanced healthcare solutions, including medical technology. This is driven by a growing awareness among consumers about the benefits of technology in improving healthcare outcomes. Patients are increasingly seeking out medical devices and equipment that can provide accurate diagnoses, effective treatments, and improved patient experiences. As a result, there is a growing demand for medical technology products such as diagnostic imaging equipment, surgical instruments, and patient monitoring devices. Trends in the market also contribute to the development of the Medical Technology market in Kuwait. The adoption of digital health technologies, such as telemedicine and remote patient monitoring, has been on the rise. These technologies allow healthcare providers to remotely monitor patients, provide consultations, and deliver personalized care, which is particularly beneficial in a country like Kuwait where access to healthcare services can be challenging in remote areas. Additionally, there is a growing focus on precision medicine, which involves tailoring medical treatments to individual patients based on their genetic makeup and other factors. This trend is driving the demand for advanced diagnostic tools and personalized medical devices. Local special circumstances in Kuwait also play a role in the development of the Medical Technology market. Kuwait has a high per capita income and a strong healthcare infrastructure, which creates a favorable environment for the adoption of medical technology. The government has been investing in the healthcare sector, including the implementation of digital health initiatives, to improve the quality and accessibility of healthcare services. Furthermore, Kuwait has a growing elderly population, which has increased the demand for medical technology products that cater to the needs of this demographic, such as assistive devices and home healthcare solutions. Underlying macroeconomic factors further contribute to the growth of the Medical Technology market in Kuwait. The country has a stable economy and a favorable business environment, which attracts international medical technology companies to invest in the market. Additionally, Kuwait has a universal healthcare system, which provides access to healthcare services for all citizens and residents. This ensures a steady demand for medical technology products and services. In conclusion, the Medical Technology market in Kuwait is developing due to customer preferences for advanced healthcare solutions, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The adoption of digital health technologies, the focus on precision medicine, the favorable business environment, and the universal healthcare system all contribute to the growth of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)